ArticleCancer chemotherapy and pharmacology2023

Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies.

Danielle Shafer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.